In a recent move that caught the attention of market observers, Clifford Sosin, a notable ten percent owner of Cardlytics, Inc. (NASDAQ:), has made a significant purchase of the company’s shares. According to the latest filings, Sosin acquired a total of 661,715 shares of Cardlytics, a leader in services related to computer programming and data processing.
The transactions, which occurred on March 15 and March 18, involved the purchase of shares at prices ranging from $13.3991 to $13.7118. The total investment amounted to approximately $8.96 million, indicating a strong vote of confidence in the future of the company from one of its major investors.
Cardlytics has been making headlines in the tech sector with its innovative advertising platform that enables banks to present customer-specific offers based on purchase data. This acquisition of shares by Sosin could be seen as an endorsement of the company’s strategy and growth prospects.
Investors and analysts often monitor insider buying as it may reflect an insider’s belief in the company’s potential for growth. With this substantial purchase, Sosin’s total holdings in Cardlytics have increased significantly, further aligning his interests with those of the company and its shareholders.
For those interested in the specifics of the ownership, it is noted that 4,060,506 of these shares are owned directly by Sosin Master, L.P., while the remaining 1,963,170 shares are owned by CSWR Partners, L.P. Clifford Sosin, through his role as the Managing Member of CAS Investment Partners, LLC, the investment manager to both entities, may be deemed to beneficially own the securities.
This recent transaction is a notable event in the financial journey of Cardlytics and will undoubtedly be followed closely by those invested in the company’s success.
InvestingPro Insights
Following the recent insider buying by Clifford Sosin at Cardlytics, Inc. (NASDAQ:CDLX), real-time data and InvestingPro Tips offer additional insights into the company’s financial health and stock performance. Cardlytics’ market capitalization stands at a solid $576.06 million, reflecting investor confidence in the company’s value proposition. Despite not being profitable in the last twelve months, the company’s revenue growth has been positive, with a 3.57% increase over the last year as of Q4 2023, and a more pronounced quarterly revenue growth of 8.08% in Q1 2023.
InvestingPro Tips highlight the stock’s significant return over the past week, with a 53.83% price total return, and an even more impressive 97.88% return over the past month. This could suggest a growing investor enthusiasm for Cardlytics’ prospects. Furthermore, the company’s liquid assets exceed its short-term obligations, providing it with a cushion to manage its moderate level of debt effectively.
For investors looking to delve deeper into Cardlytics’ performance and gain more InvestingPro Tips, visiting the dedicated page for Cardlytics on InvestingPro could provide valuable insights. There are 10 additional tips available that could help investors make more informed decisions. Interested readers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, enhancing their investment research with a suite of professional tools.
It’s also worth noting that while the stock exhibits high price volatility, which may appeal to certain investors, analysts do not anticipate the company will be profitable this year. This could be an important consideration for those looking at the long-term financial stability of Cardlytics.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Read the full article here
